Ghrelin and Diastolic Heart Function
- Conditions
- Diabetes Mellitus, Type 2Obesity, AbdominalDiastolic Dysfunction
- Interventions
- Procedure: abdominal plastic intervention
- Registration Number
- NCT05988346
- Lead Sponsor
- University of Campania "Luigi Vanvitelli"
- Brief Summary
In type 2 diabetes mellitus (T2DM) and obese patients the adipose tissue could over-express cytokines, sirtuin-1 (SIRT1), and microRNAs (miRs) implied in the regulation of left ventricle (LV) diastolic function (LV-DF). Ghrelin could modulate these pathways. Thus, in the current study authors will investigate ghrelin expression in T2DM obese patients after abdominal fat excision, and particularly in those with normalization of LV-DF at 1 year of follow-up.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- 60
- Clinical diagnosis of T2DM obese patients;
- T2DM obese patients under anti-diabetic full medical therapy and glycemic control.
- clinical diagnosis of type 1 diabetes;
- T2DM patients in poor glycemic control (HbA1c values of >7%);
- chronic neurological disorders;
- heart failure and coronary heart disease or depression of left ventricular ejection fraction (LVEF <55%);
- severe anemia;
- thyroid dysfunction;
- kidney failure;
- uncontrolled blood pressure (blood pressure > 140/90 mmHg on two occasions 2 weeks apart);
- inflammatory chronic disease;
- neoplastic disease.
Study & Design
- Study Type
- OBSERVATIONAL
- Study Design
- Not specified
- Arm && Interventions
Group Intervention Description T2DM obese patients with first degree of left ventricle (LV) diastolic dysfunction. abdominal plastic intervention - T2DM obese patients with second degree of left ventricle (LV) diastolic dysfunction. abdominal plastic intervention - type 2 diabetes mellitus (T2DM) obese patients without left ventricle (LV) diastolic dysfunction. abdominal plastic intervention -
- Primary Outcome Measures
Name Time Method normalization of LV diastolic dysfunction 12 months At 1 year of follow-up authors evaluated the patients (those with first and second degree of LV diastolic dysfunction) that will experience the normalization of LV diastolic function.
- Secondary Outcome Measures
Name Time Method
Trial Locations
- Locations (1)
Celestino Sardu
🇮🇹Naples, Italy